Login to Your Account



Financings Roundup


Thursday, August 9, 2012
• Isis Pharmaceuticals Inc., of Carlsbad, Calif., priced an offering of $201.25 million in convertible senior notes, due 2019, in a private placement.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription